| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b21f650fc35b3e1947103e89adb06f3f |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02A50-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-572
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-70
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-585
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-575
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-53
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2710-22034 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-20 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-01
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-025
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-12 |
| filingDate |
2019-01-18^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_eca2ec93bc04e71d0f1ee9684e6de2f4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_52b68638dbfc0c1d8b81497c15c786ba |
| publicationDate |
2021-01-05^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
BR-112020014632-A2 |
| titleOfInvention |
IMMUNOGENIC COMPOSITION, NUCLEIC ACID MOLECULE ENCODING A PEPTIDE, PEPTIDE, METHODS FOR INDUCING AN IMMUNE RESPONSE AGAINST A MCV T ANTIGEN IN A SUBJECT IN NEED OF THE SAME AND FOR TREATING OR PREVENTING THE NEED OF A PATHOLOGY. |
| abstract |
IMMUNOGENIC COMPOSITION, NUCLEIC ACID MOLECULE ENCODING A PEPTIDE, PEPTIDE, METHODS FOR INDUCING AN IMMUNE RESPONSE AGAINST A MCV T ANTIGEN IN A SUBJECT IN NEED OF THE SAME AND FOR TREATING OR PREVENTING THE NEED OF A PATHOLOGY.nNucleic acid molecules and compositions comprising one or more nucleotide sequences encoding a consensus Merkel Cell Polyomavirus (MCV) T antigen. Immunomodulatory methods and methods for inducing an immune response against MCV are disclosed. Methods of treating MCV infection and methods of treating or preventing Merkel Cell Carcinoma associated with MCV are disclosed. Modified consensus MCV T antigens are disclosed. |
| priorityDate |
2018-01-19^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |